These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25145464)

  • 1. Cell-based therapies for cardiac disease: a cellular therapist's perspective.
    Young PP; Schäfer R
    Transfusion; 2015 Feb; 55(2):441-51; quiz 440. PubMed ID: 25145464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations.
    Liu Z; Mikrani R; Zubair HM; Taleb A; Naveed M; Baig MMFA; Zhang Q; Li C; Habib M; Cui X; Sembatya KR; Lei H; Zhou X
    Eur J Pharmacol; 2020 Jun; 876():173049. PubMed ID: 32142771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hopes and Hurdles of Employing Mesenchymal Stromal Cells in the Treatment of Cardiac Fibrosis.
    Neuber S; Emmert MY; Nazari-Shafti TZ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells and the treatment of cardiac disease.
    Minguell JJ; Erices A
    Exp Biol Med (Maywood); 2006 Jan; 231(1):39-49. PubMed ID: 16380643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction.
    Sim WS; Park BW; Ban K; Park HJ
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart.
    Da Silva JS; Hare JM
    Methods Mol Biol; 2013; 1037():145-63. PubMed ID: 24029934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.
    Tang YL; Zhu W; Cheng M; Chen L; Zhang J; Sun T; Kishore R; Phillips MI; Losordo DW; Qin G
    Circ Res; 2009 May; 104(10):1209-16. PubMed ID: 19407239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramyocardial bone marrow mononuclear cells versus bone marrow-derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy.
    Carmona MD; Cañadillas S; Romero M; Blanco A; Nogueras S; Herrera C
    Cytotherapy; 2017 Aug; 19(8):947-961. PubMed ID: 28673775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair.
    Park BW; Jung SH; Das S; Lee SM; Park JH; Kim H; Hwang JW; Lee S; Kim HJ; Kim HY; Jung S; Cho DW; Jang J; Ban K; Park HJ
    Sci Adv; 2020 Mar; 6(13):eaay6994. PubMed ID: 32284967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair.
    Peng H; Shindo K; Donahue RR; Abdel-Latif A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular cardiac regenerative therapy in which patients?
    Chachques JC
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):911-9. PubMed ID: 19673669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases.
    Gubert F; da Silva JS; Vasques JF; de Jesus Gonçalves RG; Martins RS; de Sá MPL; Mendez-Otero R; Zapata-Sudo G
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions.
    Wei HM; Wong P; Hsu LF; Shim W
    Singapore Med J; 2009 Oct; 50(10):935-42. PubMed ID: 19907881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key developments in stem cell therapy in cardiology.
    Schulman IH; Hare JM
    Regen Med; 2012 Nov; 7(6 Suppl):17-24. PubMed ID: 23346572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Therapy: Effect of Locally Injected Mesenchymal Stromal Cells Derived from Bone Marrow or Adipose Tissue on Bone Regeneration of Rat Calvarial Defects.
    Freitas GP; Lopes HB; Souza ATP; Oliveira PGFP; Almeida ALG; Souza LEB; Coelho PG; Beloti MM; Rosa AL
    Sci Rep; 2019 Sep; 9(1):13476. PubMed ID: 31530883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.
    Oskouei BN; Lamirault G; Joseph C; Treuer AV; Landa S; Da Silva J; Hatzistergos K; Dauer M; Balkan W; McNiece I; Hare JM
    Stem Cells Transl Med; 2012 Feb; 1(2):116-24. PubMed ID: 23197758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.
    Gorodetsky R; Aicher WK
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).
    Singh A; Singh A; Sen D
    Stem Cell Res Ther; 2016 Jun; 7(1):82. PubMed ID: 27259550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we remove scar and fibrosis from adult human myocardium?
    Vazir A; Fox K; Westaby J; Evans MJ; Westaby S
    Eur Heart J; 2019 Mar; 40(12):960-966. PubMed ID: 30203057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.